Patents by Inventor Mathias Lichterfeld

Mathias Lichterfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WNT PATHWAY INHIBITORS FOR TREATING VIRAL INFECTIONS
    Publication number: 20140255426
    Abstract: In certain embodiments, the disclosure relates to methods of treating or preventing a viral infection comprising administering an effective amount of a Wnt pathway inhibitor optionally in combination with one or more anti-viral agents. In certain embodiments, the subject is diagnosed with a chronic viral infection such as human immunodeficiency virus (HIV).
    Type: Application
    Filed: March 10, 2014
    Publication date: September 11, 2014
    Applicants: EMORY UNIVERSITY, Children's Healthcare of Atlanta, Inc., The General Hospital Corporation
    Inventors: Guido Silvestri, Ann M. Chahroudi, Mathias Lichterfeld, Maria Jose Buzon, Raymond F. Schinazi
  • Soluble virus-specific T-cell receptor compositions
    Publication number: 20080015139
    Abstract: Compositions and methods for diagnosing a viral infection and methods of inhibiting such an infection are described. The methods are based on the identification of T-cell receptor gene sequences from cytotoxic T cell clones that are specific for HIV-1 or HCV. Soluble T-cell receptor compositions that bind to HLA class I-restricted of HIV and HCV pathogens were identified and constructed.
    Type: Application
    Filed: April 5, 2007
    Publication date: January 17, 2008
    Inventors: Mathias Lichterfeld, Xu Yu, Bruce Walker, Marcus Altfeld, Georg Lauer